Ildong wins Korean patents for antihypertensive agents

Published: 2010-11-18 06:56:00

Updated: 2010-11-18 06:56:00

Ildong Pharm said on November 16 that it acquired from the Korean Intellectual Property Office two patents for candesartan cilexetil and valsartan, respectively, for the treatment of hypertension.

The two patents related to more improved manufacturing process of active ingredients in the absen...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK